Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20240424061560N1Phase 3Completed
Phase 3 trial of ketamine in class III obesity, sponsored by Baqiyatallah University of Medical Sciences. Started Dec 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20240424061560N1.